Earnings Call · Q2 FY2025·2025-08-08

Q2 25EPS +33.90%·Rev n/aQ1 25EPS -2.60%·Rev n/aQ4 24EPS +18.56%·Rev n/aQ3 24EPS -7.32%·Rev n/a⚠ consensus missing

Verastem, Inc. VSTM

Julissa Viana — Investor Relations or Communications Officer

Daniel W. Paterson — President and CEO

Matthew E. Ros — Chief Medical Officer

Michael Crowther — Chief Commercial Officer

Daniel Calkins — Chief Financial Officer

+19.9%1d on move date+19.1% vs SPY3d+46.1%5d+37.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VSTM calls or request research access.

More VSTM calls Browse calls Request research access